AMN

AMN Healthcare Services, Inc. - 10-Q Summary (Period Ended Sept 30, 2008)

Business Context and Reporting Period

This is a Quarterly Report on Form 10-Q for AMN Healthcare Services, Inc., the largest healthcare staffing company in the United States, covering the three and nine months ended September 30, 2008. The Company provides temporary staffing for physicians, nurses, and allied healthcare professionals, as well as permanent physician placement services. The report includes unaudited condensed consolidated financial statements and management discussion.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 5% year-over-year for both the quarter and the nine-month period. Growth was driven by pricing increases in the locum tenens segment and acquisitions (Platinum Select Staffing in Feb 2008 and Rx Pro Health in May 2007).
• Profitability Decline: Despite revenue growth, Net Income decreased 21% for the quarter ($9.5M vs $12.0M) and 4% for the nine months ($26.7M vs $28.0M). This was primarily due to increased operating expenses, including higher compensation costs, legal/restructuring costs related to Rx Pro Health, and a higher effective tax rate.
• Segment Performance:
  • Nurse & Allied: Revenue up 6% (quarter) and 5% (9mo), aided by the Platinum Select acquisition.
  • Locum Tenens: Revenue up 3% (quarter) and 5% (9mo) due to higher bill rates and days filled.
  • Physician Placement: Revenue down 5% for the quarter but up 2% for the nine months.
• Accounting Correction: The Company identified an immaterial error in prior periods regarding the tax deductibility of housing per diem payments. While immaterial to prior periods, the correction was material to the current quarter, resulting in adjustments to liabilities and retained earnings. Historical financial statements for 2006, 2007, and Q1/Q2 2008 will be revised in future filings.

Guidance, Outlook, and Risks

• Liquidity: The Company maintains a $75 million revolving credit facility with $36.5 million outstanding. Management believes cash from operations and available borrowings are sufficient for the next 12 months, though they are monitoring the disruption in credit markets.
• Acquisitions: The Company continues to seek acquisition opportunities. The Platinum Select acquisition added $11.5 million in goodwill and $14.0 million in intangible assets.
• Stock Repurchases: The Board authorized a $38 million repurchase program through March 31, 2009. The Company repurchased 1.55 million shares for $28.4 million during the nine months ended Sept 30, 2008, with approximately $9.6 million remaining under the authorization.
• Key Risks:
  • Regulatory/Legal: An assessment by the California EDD regarding payroll taxes resulted in a $2.3 million payment (partially indemnified by prior MHA sellers). A $1.0 million liability was recorded for a claim by former Rx Pro Health employees.
  • Market Conditions: Demand in the nurse and allied segment has softened due to hospital budget concerns and increased reliance on permanent labor. Vendor management companies are tightening pricing.
  • Visa Quotas: International recruitment (OGP brand) is constrained by permanent immigrant visa quotas for nurses.

Investor Verification Checklist

• Tax Liability Exposure: Verify the final resolution of the California EDD assessment and the status of the indemnification from MHA sellers regarding the $1.8 million pre-acquisition liability.
• Revised Historicals: Monitor upcoming filings for the restatement of 2006, 2007, and Q1/Q2 2008 financials related to the per diem tax error correction.
• Debt Covenants: Confirm continued compliance with the Credit Agreement's leverage ratio (max 2.50:1) and fixed charge coverage ratio (min 1.25:1), especially given the credit market environment.
• Acquisition Integration: Assess the financial performance and integration progress of Platinum Select Staffing and Rx Pro Health, which drove revenue growth but also increased operating costs.
• International Supply Chain: Evaluate the impact of U.S. visa quotas on the O'Grady Peyton International (OGP) division, which comprises ~3% of consolidated revenue.